MESOX has just won the National Start-Up Award from Medilink UK, building upon the earlier regional win in the Midlands from Medilink Midlands in May this year. The judges highlighted two compelling reasons for their choice: MESOX’s work to develop advanced carrier technology with a mission to transform the development of pharmaceuticals, enhance bioavailability, and

MESOX and EuroAPI, a leading CDMO, are partnering to accelerate the development and manufacture of innovative drug delivery carriers. Our collaboration focuses on scaling up MESOX’s pioneering nanopore carrier technology, leveraging advanced thermodynamic models and full GMP demonstrator trials. By combining MESOX’s expertise in nanopore carrier drug delivery with EuroAPI’s established scale-up and modeling capabilities,

MESOX, a pioneering pharmaceutical company, has been awarded the prestigious Start-Up Award at the Medilink Midlands Business Awards 2024. This recognition celebrates MESOX’s outstanding achievements in life sciences, particularly its crucial work in transforming pharmaceutical formulation through its game-changing carrier technologies. This award not only highlights MESOX’s innovative approach to drug delivery but also underscores